Ads
related to: fti consulting
Search results
FTI Consulting, Inc. (NYSE:FCN) Director Sells $329,940.88 in Stock
ETF DAILY NEWS· 4 days agoFTI Consulting, Inc. (NYSE:FCN – Get Free Report) Director Gerard E. Holthaus sold 1,492 shares of...
FTI Consulting, Inc. (NYSE:FCN) Stake Increased by Van ECK Associates Corp
ETF DAILY NEWS· 6 days agoVan ECK Associates Corp lifted its stake in FTI Consulting, Inc. (NYSE:FCN – Free Report) by 35.5%...
FTI Consulting director sells shares worth over $329k By Investing.com
Investing.com· 6 days agoFTI Consulting, Inc. (NYSE:FCN) director Gerard E. Holthaus has recently sold a portion of his...
Zacks Industry Outlook Highlights FTI Consulting, Huron Consulting and CRA International
Zacks via Yahoo Finance· 5 days agoFor Immediate Release Chicago, IL – May 9, 2024 – Today, Zacks Equity Research discusses FTI ...
Insider Sale: Director Gerard Holthaus Sells Shares of FTI Consulting Inc (FCN)
GuruFocus.com via Yahoo Finance· 6 days agoOn May 7, 2024, Director Gerard Holthaus sold 1,492 shares of FTI Consulting Inc (NYSE:FCN) as...
Miller Industries, Inc. (NYSE:MLR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoMiller Industries, Inc. (NYSE:MLR) Q1 2024 Earnings Call Transcript May 11, 2024 Miller Industries,...
Invitae Receives Court Approval for Sale to Labcorp
StreetInsider· 7 days agoLabcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC: NVTAQ), a leading medical genetics company, announced today that the United States ...
Ecora Resources PLC Announces Transaction in Own Shares - 2
Morningstar· 1 day agoLONDON, UK / ACCESSWIRE / May 13, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 13 May 2024, it purchased 50,000 ordinary shares of 2p each in the Company (the "Shares") ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 20 hours ago— Almost half a million people diagnosed each year across the globe — — Collaboration based on synergistic potential of inhibiting angiogenesis and tumor-associated macrophages with HUTCHMED’s surufatinib and anti-PD-1 activity with Hengrui’s
CEOs’ top priorities for IT leaders today
CIO· 5 days agoChief executives are displaying a deeper understanding of technology’s impact on achieving organizational objectives — and they are shifting their...
